Pear Therapeutics
Article
Pear Therapeutics is a recurring organization in the Astral Codex Ten archive, appearing 2 times across 2 issues between May 12, 2021 and May 14, 2021. The archive places it in contexts such as “Pear Therapeutics released a CBT-i app”; “Pear Therapeutics created a CBT-i app”; “I’m philosophically opposed to blaming Pear Therapeutics, the company behind Somryst”. It most often appears alongside FDA, Somryst, US.
Metadata
- Category: Organizations
- Mention count: 2
- Issue count: 2
- First seen: May 12, 2021
- Last seen: May 14, 2021
Appears In
Related Pages
-
- FDA (2 shared issues)
-
- Somryst (2 shared issues)
-
- US (2 shared issues)
-
- Alexander Pope (1 shared issues)
-
- Argos (1 shared issues)
-
- Cato Institute (1 shared issues)
-
- CBT-i (1 shared issues)
-
- CBT-i Coach (1 shared issues)
-
- Cognitive Behavioral Therapy For Insomnia (1 shared issues)
-
- Deplin (1 shared issues)
-
- Diphenhydramine (1 shared issues)
-
- Dozy (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
Until now! Late last year, Pear Therapeutics released a CBT-i app (formerly “SHUT-i”, now “Somryst”) which holds the patient’s hand through the complicated CBT-i process. Studies show it works as well as a real therapist, which is very well indeed. There’s only one catch: you need a doctor’s prescription.
Inline links: Somryst
You or I could create a CBT-i app tomorrow and sell it for $1 or $10 or whatever the normal price of an app is. But it wouldn’t be official, and insurance companies wouldn’t pay for it. Pear Therapeutics created a CBT-i app, put in the work to make it official, and now they’re selling it for $899. “Our support team, PearConnect™, will help determine insurance coverage eligibility during onboarding”, says their website.
And I’m philosophically opposed to blaming Pear Therapeutics, the company behind Somryst. If you let a for-profit company charge $899 for an app, of course they’ll be all over that. I’m less interested in Somryst being greedy enough to charge $899 for an app - I assume most app makers would charge $899 if they thought they could get away with it - and more interested in why this is apparently a price that the market will bear.
See also comments from the clinical director of a digital therapeutics company, the libertarian Cato Institute’s Director of Health Policy Studies, and a former employee of Pear Therapeutics.